We are developing a disruptive technology to treat aortic diseases with a minimally invasive approach. Our first product aims at aortic dissection, a rare but lethal tear in the aorta that leads to death in up to 50% of cases. Supported by top physicians, chemists and engineers, we aim at bringing to the clinic our invention and to continue developing other non-invasive solutions for focal diseases.
aortic diseases, healthtech
💡 You’re a corporate or investor and looking for startups that are innovating in the same market as Aortyx? We’re happy to assist you with our Startup Sourcing service.